ZA200607850B - Use of PPAR delta agonists for treating demyelinating diseases - Google Patents
Use of PPAR delta agonists for treating demyelinating diseasesInfo
- Publication number
- ZA200607850B ZA200607850B ZA200607850A ZA200607850A ZA200607850B ZA 200607850 B ZA200607850 B ZA 200607850B ZA 200607850 A ZA200607850 A ZA 200607850A ZA 200607850 A ZA200607850 A ZA 200607850A ZA 200607850 B ZA200607850 B ZA 200607850B
- Authority
- ZA
- South Africa
- Prior art keywords
- demyelinating diseases
- ppar delta
- delta agonists
- treating demyelinating
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55853304P | 2004-04-01 | 2004-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200607850B true ZA200607850B (en) | 2008-10-29 |
Family
ID=34977094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200607850A ZA200607850B (en) | 2004-04-01 | 2006-09-19 | Use of PPAR delta agonists for treating demyelinating diseases |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070149580A1 (ru) |
| EP (1) | EP1737440A2 (ru) |
| JP (1) | JP2007530703A (ru) |
| KR (1) | KR20060134191A (ru) |
| CN (1) | CN1950077A (ru) |
| AU (1) | AU2005231358A1 (ru) |
| BR (1) | BRPI0509540A (ru) |
| CA (1) | CA2561159A1 (ru) |
| IL (1) | IL178165A0 (ru) |
| MA (1) | MA28561B1 (ru) |
| MX (1) | MXPA06011218A (ru) |
| NO (1) | NO20064985L (ru) |
| RU (1) | RU2006138495A (ru) |
| SG (1) | SG138623A1 (ru) |
| WO (1) | WO2005097098A2 (ru) |
| ZA (1) | ZA200607850B (ru) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007536343A (ja) | 2004-05-05 | 2007-12-13 | ノボ ノルディスク アクティーゼルスカブ | Ｐｐａｒアゴニストとしてのフェノキシ酢酸誘導体 |
| WO2005105736A1 (en) | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
| ES2372617T3 (es) | 2005-06-30 | 2012-01-24 | High Point Pharmaceuticals, Llc | Ácidos fenoxiacéticos como activadores de ppar-delta. |
| CN101336113B (zh) * | 2005-11-28 | 2015-07-29 | 千寿制药株式会社 | 包括ppar激动剂的药物 |
| CA2631390C (en) | 2005-12-22 | 2014-03-11 | Per Sauerberg | Phenoxy acetic acids as ppar delta activators |
| EP1999098A2 (en) | 2006-03-09 | 2008-12-10 | High Point Pharmaceuticals, LLC | Compounds that modulate ppar activity, their preparation and use |
| EP2288607B1 (en) | 2008-06-09 | 2014-09-24 | Sanofi | Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| US8946212B2 (en) | 2008-06-09 | 2015-02-03 | Sanofi-Aventis | Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals |
| BR112012007137A2 (pt) | 2009-09-30 | 2015-09-15 | Harvard College | metodos para modulacao da autofagia por meio da modulacao de produtos genicos inibidores da autofagia |
| WO2011084281A1 (en) | 2009-12-17 | 2011-07-14 | Sanofi-Aventis | Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging |
| WO2012112933A1 (en) * | 2011-02-18 | 2012-08-23 | The Scripps Research Institute | Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate |
| EP3043789B1 (en) | 2013-09-09 | 2020-07-08 | vTv Therapeutics LLC | Use of a ppar-delta agonists for treating muscle atrophy |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997028149A1 (en) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| WO2002013812A1 (en) * | 2000-08-17 | 2002-02-21 | Pershadsingh Harrihar A | Methods for treating inflammatory diseases |
| GB0024362D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
| GB0024361D0 (en) * | 2000-10-05 | 2000-11-22 | Glaxo Group Ltd | Medicaments |
| WO2004082621A2 (en) * | 2003-03-15 | 2004-09-30 | Bethesda Pharmaceuticals, Inc. | Novel ppar agonists, pharmaceutical compositions and uses thereof |
| US20070037882A1 (en) * | 2003-04-22 | 2007-02-15 | Astellas Pharma Inc. | Remedy for cerebral neurodegenerative diseases using ppar agonist |
-
2005
- 2005-03-29 AU AU2005231358A patent/AU2005231358A1/en not_active Abandoned
- 2005-03-29 WO PCT/US2005/010371 patent/WO2005097098A2/en active Application Filing
- 2005-03-29 SG SG200800123-2A patent/SG138623A1/en unknown
- 2005-03-29 CA CA002561159A patent/CA2561159A1/en not_active Abandoned
- 2005-03-29 MX MXPA06011218A patent/MXPA06011218A/es not_active Application Discontinuation
- 2005-03-29 JP JP2007506442A patent/JP2007530703A/ja not_active Abandoned
- 2005-03-29 RU RU2006138495/14A patent/RU2006138495A/ru not_active Application Discontinuation
- 2005-03-29 CN CNA2005800148506A patent/CN1950077A/zh active Pending
- 2005-03-29 EP EP05729215A patent/EP1737440A2/en not_active Withdrawn
- 2005-03-29 BR BRPI0509540-9A patent/BRPI0509540A/pt not_active IP Right Cessation
- 2005-03-29 KR KR1020067022955A patent/KR20060134191A/ko not_active Application Discontinuation
-
2006
- 2006-09-18 IL IL178165A patent/IL178165A0/en unknown
- 2006-09-19 ZA ZA200607850A patent/ZA200607850B/xx unknown
- 2006-09-26 US US11/535,240 patent/US20070149580A1/en not_active Abandoned
- 2006-10-31 MA MA29427A patent/MA28561B1/fr unknown
- 2006-10-31 NO NO20064985A patent/NO20064985L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005097098A2 (en) | 2005-10-20 |
| MA28561B1 (fr) | 2007-04-03 |
| JP2007530703A (ja) | 2007-11-01 |
| WO2005097098A3 (en) | 2005-12-22 |
| NO20064985L (no) | 2006-10-31 |
| IL178165A0 (en) | 2008-03-20 |
| CA2561159A1 (en) | 2005-10-20 |
| US20070149580A1 (en) | 2007-06-28 |
| SG138623A1 (en) | 2008-01-28 |
| AU2005231358A1 (en) | 2005-10-20 |
| MXPA06011218A (es) | 2007-01-16 |
| CN1950077A (zh) | 2007-04-18 |
| BRPI0509540A (pt) | 2007-09-18 |
| KR20060134191A (ko) | 2006-12-27 |
| RU2006138495A (ru) | 2008-05-10 |
| EP1737440A2 (en) | 2007-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200607850B (en) | Use of PPAR delta agonists for treating demyelinating diseases | |
| SI2001892T1 (sl) | Spojine imidazolotiazol za zdravljenje proliferacijskih bolezni | |
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| AP2006003671A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| AP2006003669A0 (en) | Sulfonamide derivatives for the treatment of diseases | |
| EP2063889A4 (en) | SPIROPIPERIDINE BETA SEKRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER DISEASE | |
| ZA200508427B (en) | Methods for treating interleuking-6 related diseases | |
| HK1171736A1 (en) | Substituted acids for the treatment of respiratory diseases | |
| EP2063896A4 (en) | KINASEHEMMER FOR THE TREATMENT OF PROLIFERATIVE DISEASES | |
| PL1817282T3 (pl) | Pochodne kwasu fenoksyoctowego użyteczne do leczenia chorób układu oddechowego | |
| ME01878B (me) | Metodi za tretiranje upalnih bolesti | |
| ATE542823T1 (de) | 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen | |
| ZA200710605B (en) | New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases | |
| EP1750513A4 (en) | USE OF GPCR54 LIGANDS FOR THE TREATMENT OF INFERTILITY | |
| PT2056804E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares | |
| GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
| EP1709155A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF DYSPROLIFERATIVE DISEASES AND METHODS OF THEIR USE | |
| EP1701735A4 (en) | METHODS AND COMPOSITIONS FOR USE IN THE TREATMENT OF DIABETES | |
| EP2039392A4 (en) | DEVICE FOR PHYSIOTHERAPY TREATMENT OF DISEASES OF VARIOUS AITIOLOGIES | |
| IL188894A0 (en) | Compounds for treatment of lipase-mediated diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
| IL175611A0 (en) | Combinations for the treatment of proliferative diseases | |
| AP2006003728A0 (en) | Compounds for treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases |